|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
386.82(B) |
Last
Volume: |
5,110,232 |
Avg
Vol: |
8,298,662 |
52
Week Range: |
$144.38 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,891 |
68,288 |
115,451 |
513,708 |
Total Sell Value |
$1,441,765 |
$10,723,734 |
$18,652,688 |
$87,322,011 |
Total People Sold |
1 |
2 |
5 |
10 |
Total Sell Transactions |
1 |
2 |
5 |
23 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cosgrove Stephen J |
Corporate Controller |
|
2013-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
29 |
482 |
|
- |
|
Caruso Dominic J |
VP, Finance; CFO |
|
2013-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
4 |
68 |
|
- |
|
Peterson Sandra E |
Group Worldwide Chairman |
|
2013-12-17 |
4 |
D |
$90.90 |
$1,106,071 |
D/D |
(12,168) |
9,521 |
|
- |
|
Peterson Sandra E |
Group Worldwide Chairman |
|
2013-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,689 |
21,689 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-12-13 |
4 |
D |
$91.16 |
$99,729 |
D/D |
(1,094) |
56,183 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-12-13 |
4 |
OE |
$53.93 |
$99,771 |
D/D |
1,850 |
57,277 |
|
- |
|
Coleman Mary Sue |
Director |
|
2013-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
13,602 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-11-30 |
4 |
A |
$0.00 |
$0 |
I/I |
20 |
100 |
|
- |
|
Perez William D |
Director |
|
2013-11-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
11,500 |
|
- |
|
Fasolo Peter |
VP, Worldwide Human Resources |
|
2013-11-01 |
4 |
D |
$93.04 |
$360,344 |
D/D |
(3,873) |
6,722 |
|
- |
|
Fasolo Peter |
VP, Worldwide Human Resources |
|
2013-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,620 |
10,595 |
|
- |
|
Mullin Leo F |
Director |
|
2013-10-16 |
4 |
D |
$89.93 |
$409,811 |
D/D |
(4,557) |
26,195 |
|
- |
|
Mullin Leo F |
Director |
|
2013-10-16 |
4 |
OE |
$53.93 |
$409,868 |
D/D |
7,600 |
30,752 |
|
- |
|
Cosgrove Stephen J |
Corporate Controller |
|
2013-08-14 |
4 |
D |
$93.01 |
$366,645 |
D/D |
(3,942) |
88,159 |
|
- |
|
Cosgrove Stephen J |
Corporate Controller |
|
2013-08-14 |
4 |
OE |
$53.93 |
$1,348,250 |
D/D |
25,000 |
89,231 |
|
- |
|
Cosgrove Stephen J |
Corporate Controller |
|
2013-08-14 |
4 |
S |
$91.39 |
$1,571,908 |
D/D |
(17,200) |
90,251 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-08-05 |
4 |
S |
$93.68 |
$1,511,995 |
D/D |
(16,140) |
55,427 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,650 |
71,567 |
|
- |
|
Cosgrove Stephen J |
Corporate Controller |
|
2013-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
31 |
453 |
|
- |
|
Ullmann Michael H |
VP, General Counsel |
|
2013-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
21 |
80 |
|
- |
|
Stoffels Paulus |
Chief Scientific Officer |
|
2013-07-25 |
4 |
S |
$92.40 |
$4,198,656 |
D/D |
(45,440) |
16,801 |
|
- |
|
Stoffels Paulus |
Chief Scientific Officer |
|
2013-07-25 |
4 |
OE |
$65.62 |
$3,502,324 |
D/D |
53,168 |
41,701 |
|
- |
|
Caruso Dominic J |
VP, Finance; CFO |
|
2013-07-18 |
4 |
S |
$90.31 |
$2,709,300 |
D/D |
(30,000) |
53,534 |
|
- |
|
Caruso Dominic J |
VP, Finance; CFO |
|
2013-07-18 |
4 |
OE |
$53.93 |
$1,617,900 |
D/D |
30,000 |
83,534 |
|
- |
|
Caruso Dominic J |
VP, Finance; CFO |
|
2013-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5 |
64 |
|
- |
|
1526 Records found
|
|
Page 26 of 62 |
|
|